Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymes.
Converting lead compounds into drug candidates is a crucial step in drug development, requiring early assessment of potency, selectivity, and off-target effects. We have utilized activity-based chemical proteomics to determine the potency and selectivity of deubiquitylating enzyme (DUB) inhibitors i...
Main Authors: | Altun, M, Kramer, H, Willems, L, McDermott, J, Leach, C, Goldenberg, S, Kumar, K, Konietzny, R, Fischer, R, Kogan, E, Mackeen, M, McGouran, J, Khoronenkova, S, Parsons, J, Dianov, G, Nicholson, B, Kessler, B |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2011
|
Similar Items
-
USP47 is a deubiquitylating enzyme that regulates base excision repair by controlling steady-state levels of DNA polymerase β.
by: Parsons, J, et al.
Published: (2011) -
Fluorescence-based active site probes for profiling deubiquitinating enzymes.
by: McGouran, J, et al.
Published: (2012) -
Deubiquitinating enzyme specificity for ubiquitin chain topology profiled by di-ubiquitin activity probes.
by: McGouran, J, et al.
Published: (2013) -
Proteome changes induced by knock-down of the deubiquitylating enzyme HAUSP/USP7.
by: Kessler, B, et al.
Published: (2007) -
The deubiquitylating enzyme UCHL3 regulates Ku80 retention at sites of DNA damage
by: Nishi, R, et al.
Published: (2018)